Growth-oriented investor and operating executive with experience sourcing and scaling technology and healthcare businesses across North America and Europe. Christopher Griffith brings expertise in corporate strategy, M&A execution and board-level governance, focusing on SaaS, fintech and healthcare services. Prior roles span investments, operating leadership and advisory work; holds a graduate business degree and is active in venture and private equity deal syndication.
Growth-oriented investor and operating executive with experience sourcing and scaling technology and healthcare businesses across North America and Europe. Christopher Griffith brings expertise in corporate strategy, M&A execution and board-level governance, focusing on SaaS, fintech and healthcare services. Prior roles span investments, operating leadership and advisory work; holds a graduate business degree and is active in venture and private equity deal syndication.
Adopts a growth-oriented, operationally grounded investment approach focused on SaaS, fintech and healthcare services across North America and Europe. Prefers founder-led companies where active board engagement, strategic M&A and scalable go-to-market execution accelerate value creation. Allocates capital to recurring-revenue models with unit-economics visibility, backing rounds that fund product-market fit and commercial scaling. Risk managed by stage diversification, deep due diligence, and hands-on operational involvement to de-risk execution over a 3–7 year horizon.
Adopts a growth-oriented, operationally grounded investment approach focused on SaaS, fintech and healthcare services across North America and Europe. Prefers founder-led companies where active board engagement, strategic M&A and scalable go-to-market execution accelerate value creation. Allocates capital to recurring-revenue models with unit-economics visibility, backing rounds that fund product-market fit and commercial scaling. Risk managed by stage diversification, deep due diligence, and hands-on operational involvement to de-risk execution over a 3–7 year horizon.
| Trades 2421 | Longs Won 1691/2421 69% | Profit Factor 7.98 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $464,094.19 |
| Average Win $143,185.14 | Best Trade (Mar 31) $9.06M | Sharpe Ratio -10.37 |
| Average Loss -$41,547.98 | Worst Trade (Dec 31) -$2.03M | Z-Score 13.79 (100%) |
| Commissions $0 | Avg. Trade Length 1y 5m 3w 3d | Expectancy $87,482.88 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 17,544 | 15,789 | 14,035 | 12,281 | 10,526 | 8,772 | 7,018 | 5,263 | 3,509 | 1,754 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 72,741 | $14M | $25.08M | - | $11.08M | 79.18% | +0.81% |
ABBV AbbVie Inc. | 21,670 | $3.53M | $6.16M | - | $2.63M | 74.31% | +0.314% |
ABT Abbott Laboratories | 21,947 | $2.42M | $2.29M | - | -$131,996.08 | -5.45% | -0.277% |
ACHR Archer Aviation Inc. | 178,188 | $1.3M | $728,788.92 | - | -$575,589.26 | -44.13% | -4.215% |
ADI Analog Devices, Inc. | 2,410 | $479,121.24 | $983,545.1 | - | $504,423.86 | 105.28% | +1.03% |
AGZ iShares Agency Bond ETF | 2,456 | $269,388.82 | $262,104.32 | - | -$7,284.5 | -2.7% | -0.056% |
AIG American International Group Inc. | 22,161 | $1.58M | $1.78M | - | $202,775.56 | 12.86% | +1.504% |
AMAT Applied Materials, Inc. | 6,045 | $1M | $2.52M | - | $1.52M | 151.68% | -3.021% |
AMD Advanced Micro Devices, Inc. | 9,178 | $1.34M | $4.98M | - | $3.64M | 272.19% | -3.584% |
AMGN Amgen Inc. | 31,144 | $9.4M | $13.55M | - | $4.15M | 44.1% | +0.253% |
AMZN Amazon.com Inc | 43,401 | $6.96M | $10.99M | - | $4.03M | 57.92% | -0.62% |
ANET Arista Networks, Inc. | 9,582 | $1.07M | $1.73M | - | $659,873.01 | 61.9% | -2.942% |
APD Air Products and Chemicals, Inc. | 5,975 | $1.64M | $1.78M | - | $143,329.44 | 8.75% | +0.477% |
APO Apollo Global Management, Inc. | 13,024 | $1.3M | $1.48M | - | $181,370.13 | 13.97% | +1.546% |
ARCC Ares Capital Corporation | 11,431 | $249,721.04 | $215,188.57 | - | -$34,532.47 | -13.83% | -0.502% |
ARKK ARK Innovation ETF Fund | 6,072 | $294,528.05 | $503,429.52 | - | $208,901.47 | 70.93% | -3.244% |
ASML ASML Holding N.V. New York Registry Shares | 178 | $120,228.24 | $297,082 | - | $176,853.76 | 147.1% | +0.697% |
AVGO Broadcom Inc. | 35,058 | $5.86M | $11.73M | - | $5.86M | 99.97% | -2.849% |
AXP American Express Company | 6,235 | $1.24M | $1.97M | - | $736,172.79 | 59.55% | +0.79% |
AZN AstraZeneca PLC American Depositary Shares | 11,000 | $2.17M | $1.82M | - | -$348,856.57 | -16.09% | -0.81% |